📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection. (2021)

First Author: Banham GD

Attributed to: Determining functional immunity after SARS-CoV-2 vaccination or natural infection in haemodialysis patients at high-risk of COVID-19 funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1681/asn.2021020188

PubMed Identifier: 34341181

Publication URI: http://europepmc.org/abstract/MED/34341181

Type: Journal Article/Review

Volume: 32

Parent Publication: Journal of the American Society of Nephrology : JASN

Issue: 9

ISSN: 1046-6673